Kenton Stewart
Sales & Marketing bij UROVANT SCIENCES LTD.
Profiel
Kenton Stewart is a professional who has worked in the pharmaceutical industry for over a decade.
He is currently a Senior Vice President-Market Access at Urovant Sciences Ltd.
He previously worked at Astellas Pharma US, Inc. for 12 years, where he held the position of Senior Vice President-Health Systems.
Stewart holds a Master's in Business Administration from Bellevue University and an undergraduate degree from Wichita State University.
Actieve functies van Kenton Stewart
| Bedrijven | Functie | Begin |
|---|---|---|
| UROVANT SCIENCES LTD. | Sales & Marketing | 02-06-2020 |
Eerdere bekende functies van Kenton Stewart
| Bedrijven | Functie | Einde |
|---|---|---|
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Kenton Stewart
| Bellevue University | Masters Business Admin |
| Wichita State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
